MR

Mahalakshmi Ramasubramaniam

Director DIN 01927760
DIN 01927760 First appointment Jul 2009
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahalakshmi Ramasubramaniam

Data last updated:

Mahalakshmi Ramasubramaniam was a Director at Vrs Health Investments Private Limited (from 2009) and Director at Thinkgenome Labs Private Limited (from 2011).

DIN 01927760
First Appointment 09 Jul 2009
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jul 20092009Strike Off
Thinkgenome Labs Private Limited U24234KA2008PTC046420
Director30 Mar 20112008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vrs Health Investments Private Limited
Thinkgenome Labs Private Limited
Premium access

Shareholding and investment profile for Mahalakshmi Ramasubramaniam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahalakshmi Ramasubramaniam

Mahalakshmi Ramasubramaniam was first appointed on 09 Jul 2009 as Director at Vrs Health Investments Private Limited. The most recent appointment on record is 30 Mar 2011 at Thinkgenome Labs Private Limited.

Mahalakshmi Ramasubramaniam held 2 earlier board appointments: Vrs Health Investments Private Limited (Director, from 09 Jul 2009); Thinkgenome Labs Private Limited (Director, from 30 Mar 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available